Literature DB >> 8280062

Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.

G Mascellani1, L Liverani, P Bianchini, B Parma, G Torri, A Bisio, M Guerrini, B Casu.   

Abstract

Dermatan sulphate (DS) obtained from bovine and pig mucosa and pig skin, and charge-enriched fractions of a selected DS preparation, were characterized in terms of charge density, M(r) and disaccharide composition of chondroitin ABC lyase digests, and by 13C-n.m.r. spectroscopy. Besides the major IdoA-GalNAc4SO3 sequences, all DS preparations contain about 10% disulphated disaccharide sequences (mostly IdoA2SO3-GalNAc4SO3, with minor amounts of IdoA-GalNAc4,6SO3). DS fragments (prepared by radical-catalysed depolymerization of DS and retaining the internal structure of the parent polysaccharide) as well as Smith degraded fragments [SD-DS, obtained by controlled degradation of periodate-oxidized and borohydride-reduced DS (RO-DS)] with the general structure GalNAc4SO3(IdoA2SO3-GalNAc4SO3)n-R (where R is the remnant of a glycol-split uronic acid, and n = 2-3 and 3-4) were characterized by one- and two-dimensional 1H-n.m.r., 13C-n.m.r. and disaccharide composition analysis. In accordance with previous findings [Maimone and Tollefsen (1990) J. Biol. Chem. 265, 18263-18271], only fragments with n > or = 3 significantly enhance the heparin cofactor II-mediated inhibition of thrombin. In natural DS preparations and their fractions, this activity (as well as the antithrombotic activity in an animal model) appears to require IdoA2SO3-containing sequences. The heparin cofactor II activity of DS, RO-DS and SD-DS fragments decreases with decreasing M(r). However, RO-DS fragments are more active than DS fragments of similar M(r), probably because of the extra flexibility endowed by glycol-split IdoA residues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280062      PMCID: PMC1137745          DOI: 10.1042/bj2960639

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

Review 1.  Physicochemical aspects of heparin cofactor II.

Authors:  C W Pratt; H C Whinna; J B Meade; R E Treanor; F C Church
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

2.  Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.

Authors:  M F Scully; V Ellis; N Seno; V V Kakkar
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

Review 3.  Proteoglycans: an overview.

Authors:  D Heinegård; Y Sommarin
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Isolation and characterization of dermatan sulfate proteoglycans synthesized by cultured bovine aortic endothelial cells.

Authors:  M G Kinsella; T N Wight
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

5.  [Potentiometry applied to the characterization and analysis of polysaccharides for pharmaceutical use].

Authors:  G Mascellani; A Rasconi; E Brugnoli; P Bianchini
Journal:  Farmaco Prat       Date:  1988-05

6.  Isolation of dermatan sulfate with high heparin cofactor II-mediated thrombin-inhibitory activity from porcine spleen.

Authors:  H Munakata; C C Hsu; C Kodama; J Aikawa; M Sakurada; N Ototani; M Isemura; Z Yosizawa; N Hayashi
Journal:  Biochim Biophys Acta       Date:  1987-09-11

7.  Chondroitinase ABC digestion of dermatan sulphate. N.m.r. spectroscopic characterization of the oligo- and poly-saccharides.

Authors:  P N Sanderson; T N Huckerby; I A Nieduszynski
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

8.  Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography.

Authors:  K Yoshida; S Miyauchi; H Kikuchi; A Tawada; K Tokuyasu
Journal:  Anal Biochem       Date:  1989-03       Impact factor: 3.365

9.  A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.

Authors:  D Dupouy; P Sié; F Dol; B Boneu
Journal:  Thromb Haemost       Date:  1988-10-31       Impact factor: 5.249

10.  Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II.

Authors:  P Sié; M Petitou; J C Lormeau; D Dupouy; B Boneu; J Choay
Journal:  Biochim Biophys Acta       Date:  1988-08-11
View more
  8 in total

1.  Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.

Authors:  S F Penc; B Pomahac; E Eriksson; M Detmar; R L Gallo
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Microbial adherence to and invasion through proteoglycans.

Authors:  K S Rostand; J D Esko
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

3.  Structural determination of novel tetra- and hexasaccharide sequences isolated from chondroitin sulfate H (oversulfated dermatan sulfate) of hagfish notochord.

Authors:  C Ueoka; S Nadanaka; N Seno; K H Khoo; K Sugahara
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

4.  Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.

Authors:  Tusar K Giri; Douglas M Tollefsen
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

Review 5.  High-field NMR as a technique for the determination of polysaccharide structures.

Authors:  B Mulloy
Journal:  Mol Biotechnol       Date:  1996-12       Impact factor: 2.695

6.  Effects of dermatan sulfate derivatives on platelet surface P-selectin expression and protein C activity in blood of inflammatory bowel disease patients.

Authors:  Sheng-Li Ji; Hai-Yan Du; Yan-Qing Chi; Hui-Fei Cui; Ji-Chao Cao; Mei-Yu Geng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

7.  Biochemical characterization of the chondroitinase ABC I active site.

Authors:  Vikas Prabhakar; Rahul Raman; Ishan Capila; Carlos J Bosques; Kevin Pojasek; Ram Sasisekharan
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 8.  Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery.

Authors:  Suniti Misra; Vincent C Hascall; Ilia Atanelishvili; Ricardo Moreno Rodriguez; Roger R Markwald; Shibnath Ghatak
Journal:  Int J Cell Biol       Date:  2015-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.